AI assistant
Sending…
BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2013
May 17, 2013
30583_dirs_2013-05-17_10ff2dbc-ee12-496f-b80e-afcfa854216c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2013-05-15
Reporting Person: Ajer Jeffrey Robert (SVP, Chief Commercial Of)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-05-15 | Common Stock | A | 8400 | — | Acquired | 15670 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-05-15 | Stock Option (right to buy) Common Stock | $67.81 | A | 49000 | Acquired | 2023-05-14 | Common Stock (49000) | Direct |
Footnotes
F1: Restricted stock units granted on May 15, 2013. Price not applicable.
F2: Option grant vests 6/48ths on November 15, 2013 and 1/48th on the 15th day of every month thereafter.
More from BIOMARIN PHARMACEUTICAL INC
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 4
Interim / Quarterly Report
2026
May 5
Report Publication Announcement
2026
May 4
M&A Activity
2026
Apr 27
M&A Activity
2026
Apr 23
Annual Report
2026
Apr 21
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19